Showing 1 - 16 results of 16 for search 'Jan D Lünemann', query time: 0.06s
Refine Results
-
1
-
2
-
3
Fc-Receptor Targeted Therapies for the Treatment of <i>Myasthenia gravis</i> by Christian W. Keller, Marc Pawlitzki, Heinz Wiendl, Jan D. Lünemann
Published 2021-05-01
Article -
4
Antibody-mediated cell depletion therapies in multiple sclerosis by Alice Mariottini, Alice Mariottini, Paolo A. Muraro, Jan D. Lünemann
Published 2022-09-01
Article -
5
-
6
Profiling Complement System Components in Primary CNS Vasculitis by Milani Deb-Chatterji, Christian W. Keller, Simon Koch, Heinz Wiendl, Christian Gerloff, Tim Magnus, Jan D. Lünemann
Published 2021-05-01
Article -
7
Impact of disease‐modifying therapies on humoral and cellular immune‐responses following SARS‐CoV‐2 vaccination in MS patients by Susan Trümpelmann, Andreas Schulte‐Mecklenbeck, Olga V. Steinberg, Timo Wirth, Manfred Fobker, Lisa Lohmann, Jan D. Lünemann, Heinz Wiendl, Catharina C. Gross, Luisa Klotz
Published 2022-07-01
Article -
8
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein by Kristina Kakalacheva, Stephan Regenass, Silke Wiesmayr, Tarik Azzi, Christoph Berger, Russell C. Dale, Fabienne Brilot, Christian Münz, Kevin Rostasy, David Nadal, Jan D. Lünemann
Published 2016-02-01
Article -
9
Association of polysialic acid serum levels with schizophrenia spectrum and bipolar disorder-related structural brain changes and hospitalization by Louisa Müller-Miny, Katharina Thiel, Susanne Meinert, Tim Hahn, Tilo Kircher, Igor Nenadić, Axel Krug, Felix Hufschmidt, Huan Liao, Harald Neumann, Udo Dannlowski, Jan D. Lünemann
Published 2023-02-01
Article -
10
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis by Christian W. Keller, Tobias Ruck, Donal McHugh, Steffen Pfeuffer, Catharina C. Gross, Catharina Korsukewitz, Nico Melzer, Luisa Klotz, Sven G. Meuth, Christian Münz, Falk Nimmerjahn, Heinz Wiendl, Jan D. Lünemann
Published 2019-12-01
Article -
11
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. by Nicole Caduff, Donal McHugh, Anita Murer, Patrick Rämer, Ana Raykova, Vanessa Landtwing, Lisa Rieble, Christian W Keller, Michael Prummer, Laurent Hoffmann, Janice K P Lam, Alan K S Chiang, Friedrich Raulf, Tarik Azzi, Christoph Berger, Tina Rubic-Schneider, Elisabetta Traggiai, Jan D Lünemann, Michael Kammüller, Christian Münz
Published 2020-04-01
Article -
12
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. by Nicole Caduff, Donal McHugh, Anita Murer, Patrick Rämer, Ana Raykova, Vanessa Landtwing, Lisa Rieble, Christian W Keller, Michael Prummer, Laurent Hoffmann, Janice K P Lam, Alan K S Chiang, Friedrich Raulf, Tarik Azzi, Christoph Berger, Tina Rubic-Schneider, Elisabetta Traggiai, Jan D Lünemann, Michael Kammüller, Christian Münz
Published 2020-12-01
Article -
13
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response by Valerie E. Teschner, Ann-Katrin Fleck, Carolin Walter, Anna-Sophie Schwarze, Melanie Eschborn, Timo Wirth, Olga V. Steinberg, Andreas Schulte-Mecklenbeck, I-Na Lu, Marisol Herrera-Rivero, Claudia Janoschka, Jan D. Lünemann, Nicholas Schwab, Gerd Meyer zu Hörste, Julian Varghese, Catharina C. Gross, Refik Pul, Christoph Kleinschnitz, Simone Mader, Edgar Meinl, Monika Stoll, Heinz Wiendl, Luisa Klotz
Published 2023-12-01
Article -
14
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline by Antonios Bayas, Achim Berthele, Norbert Blank, Peter Dreger, Simon Faissner, Manuel A. Friese, Lisa-Ann Gerdes, Oliver Martin Grauer, Vivien Häussler, Christoph Heesen, Dietlinde Janson, Mirjam Korporal-Kuhnke, Markus Kowarik, Nikolaus Kröger, Jan D. Lünemann, Roland Martin, Uwe Meier, Sven Meuth, Paolo Muraro, Michael Platten, Lucas Schirmer, Klarissa Hanja Stürner, Jan Patrick Stellmann, Christof Scheid, Florian Then Bergh, Clemens Warnke, Brigitte Wildemann, Tjalf Ziemssen
Published 2023-09-01
Article -
15
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination by Fiona Tea, Joseph A. Lopez, Sudarshini Ramanathan, Vera Merheb, Fiona X. Z. Lee, Alicia Zou, Deepti Pilli, Ellis Patrick, Anneke van der Walt, Mastura Monif, Esther M. Tantsis, Eppie M. Yiu, Steve Vucic, Andrew P. D. Henderson, Anthony Fok, Clare L. Fraser, Jeanette Lechner-Scott, Stephen W. Reddel, Simon Broadley, Michael H. Barnett, David A. Brown, Jan D. Lunemann, Russell C. Dale, Fabienne Brilot, the Australasian and New Zealand MOG Study Group
Published 2019-09-01
Article -
16
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper) by Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuss, Ralf Linker, Mathias Mäurer, Orhan Aktas, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czaplinski, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans-Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding-Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp
Published 2021-08-01
Article